Skip to content
Recall Observatory FDA recall evidence

Drug product

Spironolactone Tablets, USP, 25 mg, packaged in: a) 30-count bottles (NDC 63629-1064-01), b) 60-count bottles (NDC 63629-1064-02), c) 90-count bottles (NDC 63629-1064-03), Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA

D-0303-2021

January 27, 2021

Class I

Product summary

Firm
Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals
Event
Event 87283
Status
Ongoing
Classification
Class I
Quantity
35 bottles
Official record key
drug-enforcement:D-0303-2021

Official wording

Reason: Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 25 mg may contain spironolactone 50 mg tablets.

Code information: a) Lot #: 148969, Exp 7/31/2022, b) Lot #: 148791, Exp 7/31/2022, c) Lot #: 148991, Exp 7/31/2022

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Labeling or packaging

    reason.labeling_packaging · v1.0.0

    Labeling: Label Mix-Up